RT @UMichPath: 📰NEW PUBLICATION: "Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases" from #UMichP…
Great new work recently published from the Lieberman lab!
RT @Henrypaulson5: Congrats Mark (and the whole Lieberman team)! Happy to be part of this significant advance for a vexing disease. https:/…
RT @Henrypaulson5: Congrats Mark (and the whole Lieberman team)! Happy to be part of this significant advance for a vexing disease. https:/…
RT @UMichPath: 📰NEW PUBLICATION: "Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases" from #UMichP…
RT @Henrypaulson5: Congrats Mark (and the whole Lieberman team)! Happy to be part of this significant advance for a vexing disease. https:/…
RT @Henrypaulson5: Congrats Mark (and the whole Lieberman team)! Happy to be part of this significant advance for a vexing disease. https:/…
Congrats Mark (and the whole Lieberman team)! Happy to be part of this significant advance for a vexing disease.
RT @UMichPath: 📰NEW PUBLICATION: "Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases" from #UMichP…
📰NEW PUBLICATION: "Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases" from #UMichPath Drs. Andrew Lieberman and Mark Schultz and their team, published in @BioMedCentral: ℹ️https://t.co/2tuf8ACAXY @Henrypaulson5 #Pa
Just Published: Researchers from @UMich @umichmedicine show that synthetic high-density lipoprotein #nanoparticles are a potential new therapeutic avenue for Niemann–Pick diseases. Read more at https://t.co/EK4Jw0ljDL. #neuromusculardisorders https://t.co/